Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Gus Theodos"'
Publikováno v:
American Journal of Cardiovascular Drugs. 20:611-617
Current guidelines recommend direct-acting oral anticoagulants (DOACs) over warfarin in patients with atrial fibrillation (AF) and valvular heart disease (VHD) without a mechanical valve or moderate to severe mitral stenosis. However, real-world data
Autor:
William J. Nicholson, Keith B. Allen, Paul T. Tolerico, Mark W. Burlingame, James E. Harvey, Gus Theodos, Adnan K. Chhatriwalla
Publikováno v:
Structural Heart. 3:255-257
Valve-in-Valve Transcatheter aortic valve replacement (VIV TAVR) for treatment of failed bioprosthetic surgical valves has been shown to be a safe and effective alternative to reoperation for patie...
Autor:
Stephen G. Ellis, Russell E. Raymond, Chad Raymond, Gus Theodos, Matthew C. Becker, Julie Thornton, Deepak L. Bhatt
Publikováno v:
Catheterization and Cardiovascular Interventions. 81:294-300
Objectives To investigate the safety and risk of vascular complications of arteriotomy closure devices (ACD) with the direct thrombin inhibitor bivalirudin in patients undergoing percutaneous coronary intervention (PCI). Background ACDs and manual co
Publikováno v:
Interventional Cardiology. 3:171-189
Cardiovascular consultants are increasingly faced with patients presenting with multiple comorbidities or structural challenges, who are in need for anatomical corrections. In such patients, hybrid cardiovascular procedures often allow for collaborat
Publikováno v:
Texas Heart Institute journal. 41(4)
A 64-year-old man with refractory angina and a history of revascularization was referred after a failed attempt at revascularization. His medical regimen included maximal β-blocker, calcium channel blocker, and nitrate therapy. Cineangiograms before
Autor:
Stephen G. Ellis, Andrew N. Rassi, Michael Militello, Eugene H. Blackstone, Matthew A. Cavender, Zhiyuan Sun, Leslie Cho, Gus Theodos
Publikováno v:
The American journal of cardiology. 110(4)
Patients with previously implanted coronary stents are at risk for stent thrombosis if dual-antiplatelet therapy is prematurely discontinued. Bridging with a glycoprotein IIb/IIIa inhibitor has been advocated as an alternative, with few supporting da
Autor:
Takashi Akasaka, Ibrahim Akin, Jorge R. Alegria, Alexandra Almonacid, Carlos L. Alviar, Dominick J. Angiollilo, Gary M. Ansel, Saif Anwaruddin, David T. Balzer, Amr T. Bannan, Gregory W. Barsness, Robert H. Beekman, Farzin Beygui, John A. Bittl, Philipp Bonhoeffer, Michael Braendle, J. Matthew Brennan, Ralph Brindis, Eric Brochet, David Burke, Heinz Joachim Büttner, Robert Byrne, Christopher P. Cannon, Ivan P. Casserly, Matthews Chacko, Derek P. Chew, Leslie Cho, Louise Coats, Antonio Colombo, Marco A. Costa, Alain Cribier, Kevin J. Croce, Fernando Cura, Gregory J. Dehmer, Robert S. Dieter, John S. Douglas, Helene Eltchaninoff, Marvin H. Eng, Peter J. Fitzgerald, Valentin Fuster, Mario J. Garcia, Scot Garg, Jeffrey Goldstein, Nilesh J. Goswani, William A. Gray, Giulio Guagliumi, Hidehiko Hara, Rani Hasan, Timothy D. Henry, Howard C. Herrmann, Dominique Himbert, Russel Hirsch, David R. Holmes, Yasuhiro Honda, Hüseyin Ince, Bernard Iung, Hani Jneid, Samuel L. Johnston, James G. Jollis, David Kandzari, Samir R. Kapadia, Adnan Kastrati, Dean J. Kereiakes, Morton J. Kern, Ahmed A. Khattab, Young-Hak Kim, Ajay J. Kirtane, Raghu Kolluri, Amar Krishnaswamy, Takashi Kubo, Roger Laham, John Lasala, Michael J. Lim, Thomas R. Lloyd, Daniel Mark, Bernhard Meier, Gilles Montalescot, Pedro R. Moreno, Jeffrey W. Moses, Arashk Motiei, Debabrata Mukherjee, Srihari S. Naidu, Brahmajee K. Nallamothu, Craig R. Narins, Gjin Ndrepepa, Franz-Josef Neumann, Christoph A. Nienaber, Masakiyo Nobuyoshi, Igor Palacios, Seung-Jung Park, Uptal D. Patel, Marc S. Penn, Jeffrey Popma, Matthew J. Price, Vivek Rajagopal, Kausik K. Ray, G. Russell Reiss, Krishna Rocha-Singh, Marco Roffi, R. Kevin Rogers, Javier Sanz, Bruno Scheller, Albert Schömig, Robert S. Schwartz, Patrick Serruys, Shinichi Shirai, Mehdi H. Shishehbor, Mitchell J. Silver, Daniel I. Simon, Vasile Sirbu, Goran Stankovic, Curtiss Stinis, Gregg W. Stone, Gus Theodos, On Topaz, Christophe Tron, Alec Vahanian, Robert A. Van Tassel, Christopher J. White, Matthew R. Williams, Paul Yock, Hiroyoshi Yokoi, Alan Zajarias, Khaled Ziada, Andrew A. Ziskind, Matthew Zussman
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb25d2decf9130d118f63cd6a3b2a5a1
https://doi.org/10.1016/b978-1-4377-2358-8.00069-3
https://doi.org/10.1016/b978-1-4377-2358-8.00069-3
Autor:
Gus, Theodos, Chad, Raymond, Matthew C, Becker, Julie, Thornton, Stephen G, Ellis, Deepak L, Bhatt, Russell E, Raymond
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 81(2)
To investigate the safety and risk of vascular complications of arteriotomy closure devices (ACD) with the direct thrombin inhibitor bivalirudin in patients undergoing percutaneous coronary intervention (PCI).ACDs and manual compression have been sho